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Identity 
Other names: EC 2.7.11.1; WARTS; h-warts; wts 
HGNC (Hugo): LATS1 
Location: 6q25.1 




The LATS1 gene contains 8 exons, ranging in size 
from 106 bp to 1513 bp. The mRNA transcript spans 
4756 bp. 
Transcription 
An alternatively spliced variant was identified in 
vertebrate retina and testis. This smaller variant has 
deletions of exon 6, 7, and 8. The functional 
significance of this splice variant is not known. 
Protein 
Description 
LATS1 is a highly conserved Ser/Thr kinase that 
belongs to the AGC (Protein kinase A/G/C) family of 
protein kinases. Within the C-terminal kinase  
domain lie two conserved residues, Ser909 and 
Thr1079, which are phosphorylated upon activa-tion. 
The N-terminus of LATS1 contains two PPxY motifs, 
which bind to WW-domain transcriptional co-
activators TAZ and YAP, as well as a protein binding 
domain (PBD) that has been shown to bind to MOB1 
and cytoskeletal proteins LIMK1 and Zyxin. In 
addition, an ubiquitin binding domain (UBA) and a 
proline-rich region (P-stretch) have been identified n 
the N-terminal region of LATS1, although the 
functional significance of these domains has not yet 
been determined. 
Expression 
LATS1 is ubiquitously expressed. 
Localisation 
LATS1 is primarily localized within the cytoplasm, 
however, LATS1 possesses functions that require its 
translocation to the nucleus. The mechanism of 
translocation is not yet understood. 
Function 
As a tumor suppressor, LATS1 functions as a key 
regulator of cell cycle progression, apoptosis, andcell 
migration. As cell cycle regulator, LATS1 is able to 
modulate multiple aspects of the cell cycle, including 
G2/M arrest, mitotic exit, activation of  
 






Atlas Genet Cytogenet Oncol Haematol. 2010; 14(4)  398 
 
 
the G1 tetraploidy checkpoint, and regulation of 
cytokinesis. LATS1 also promotes apoptosis by 
inducing expression of pro-apoptotic proteins BAX, 
caspase 3 and tumor suppressor p53. Finally, loss of 
LATS1 has been shown to enhance the rate of cell 
migration. 
HIPPO-LATS Signaling Pathway: LATS1 is a key 
player in the conserved Hippo-LATS signaling 
pathway. Components of this pathway include the 
adaptor proteins WW45 and MOB, which aid in 
bringing LATS in contact with the kinase MST1/ 
MST2. MST1/2 can then phosphorylate and activate 
LATS1. Upstream of MST1/2 lay FERM domain 
proteins Willin/FRMD6 and Merlin/NF2, as well as a 
protocadherin FAT4. The molecular mechanisms 
regulating this pathway have not yet been delineated in 
a mammalian system. Down-stream of LATS1 lay two 
transcriptional co-activators, YAP and TAZ, which are 
phosphoryla-ted and inhibited by LATS1, thereby 
sequestering them in the cytoplasm. Finally, YAP and
TAZ have been shown to act through the TEAD/TEF 
family of transcription factors to modulate the 
expression of a variety of genes (See figure below). 
Function-ally, the Hippo-LATS pathway has been 
implicated in cell proliferation, apoptosis, the epithelial 
mesen-chymal transition, and cell migration. 
Homology 
The LATS1 kinase domain is conserved across species. 
Human homologs include LATS2 and the nuclear 
Dbf2-related kinases, NDR1 and NDR2. 
Mutations 
Note 





There is increasing evidence that LATS1 is 
downregulated in a variety of human tumor types. To 
date, loss of LATS1 has been found in soft tissue 
sarcomas, particularly myxoid liposarcoma, 
leiomyosarcoma, and malignant fibrous histocyto-mas, 
as well as ovarian cancer, breast cancer, acute 
lymphoblastic leukemia, and astrocytoma. Prima-rily 
downregulation of LATS1 expression is due to 
hypermethylation of the promoter region. 
Prognosis 
Decreased LATS1 expression in breast cancer is 
associated with large tumor size, high lymph node 
metastasis, and estrogen and progesterone nega-tivity. 
Thus, loss of LATS1 is associated with poor prognosis 
in breast cancer. Furthermore, loss of LATS1 
expression, in addition to other genes, can be useda  a 
prognostic factor in predicting disease-free survival for 
acute lymphoblastic leukemia. 
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